Billiontoone, Inc. (NASDAQ:BLLN) Given Average Recommendation of “Moderate Buy” by Brokerages

Billiontoone, Inc. (NASDAQ:BLLN) has earned a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $135.2857.

Several equities analysts have commented on BLLN shares. Zacks Research raised shares of Billiontoone to a “hold” rating in a research report on Tuesday, December 2nd. Piper Sandler reiterated an “overweight” rating on shares of Billiontoone in a report on Wednesday, December 10th. JPMorgan Chase & Co. reduced their price objective on shares of Billiontoone from $150.00 to $145.00 and set an “overweight” rating on the stock in a report on Wednesday, December 10th. Jefferies Financial Group began coverage on Billiontoone in a research report on Monday, December 1st. They set a “hold” rating and a $117.00 target price on the stock. Finally, Stifel Nicolaus initiated coverage on shares of Billiontoone in a report on Monday, December 1st. They issued a “buy” rating and a $145.00 target price for the company.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of BLLN. Adams Street Partners LLC purchased a new position in shares of Billiontoone during the fourth quarter worth about $140,063,000. Baillie Gifford & Co. acquired a new position in Billiontoone in the 4th quarter valued at $103,786,000. JPMorgan Chase & Co. purchased a new position in Billiontoone during the 4th quarter worth $32,078,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Billiontoone in the 4th quarter worth $18,631,000. Finally, Capital International Investors acquired a new stake in shares of Billiontoone in the 4th quarter worth $14,568,000.

Billiontoone Trading Down 1.2%

Shares of NASDAQ:BLLN opened at $88.61 on Friday. The company has a fifty day moving average of $90.47. The stock has a market cap of $4.06 billion and a PE ratio of 886.10. Billiontoone has a 52-week low of $80.00 and a 52-week high of $138.70.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings data on Tuesday, December 9th. The company reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.06). The company had revenue of $83.52 million during the quarter, compared to analysts’ expectations of $82.86 million.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.